Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3068% below fair value
$3.86−0.31 (-7.43%)
Close on Nov 12, 2026Market cap $72.56MP/E –Yield –
Outset Medical statistics
86 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Jan 11, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.87
- 4.85
Enterprise valuationIndustry
- EV / Sales
- 0.28
- 2.70
Share statisticsIndustry
- Shares Change (YoY)
- 60.6%
- 3.22%
- Shares Change (QoQ)
- 0.40%
- 0.16%
- Float
- 12M
- 37M
- Shares Held by Insiders
- 35.1%
- 10.5%
- Shares Held by Institutions
- 75.5%
- 60.2%
Short sellingIndustry
- Short Interest
- 812,767
- –
- Short Interest Change
- -12.8%
- -2.57%
- Short % of Float
- 6.66%
- 5.12%
- Short % of Shares Outstanding
- 4.32%
- 3.98%
- Days to Cover
- 8.61
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $6.49
- –
- 52-Week Low
- $2.84
- –
- 20-Day Moving Average
- $4.13
- –
- 50-Day Moving Average
- $3.75
- –
- 200-Day Moving Average
- $4.10
- –
- Average True Range (14)
- $0.32
- –
- Price Change (1 Week)
- -5.85%
- 2.01%
- Price Change (1 Month)
- 0.52%
- -0.57%
- Price Change (3 Months)
- -14.4%
- -7.91%
- Price Change (6 Months)
- 1.31%
- -0.90%
- Price Change (YTD)
- 4.04%
- -0.82%
- Price Change (1 Year)
- -37.9%
- -1.18%
- Price Change (3 Years)
- -93.9%
- 6.56%
- Price Change (5 Years)
- -99.5%
- -49.8%
- Average Volume (10 Days)
- 111,624
- –
- Average Volume (20 Days)
- 104,140
- –
- Average Volume (90 Days)
- 142,909
- –
- Relative Volume
- 1.12
- 0.82
- Relative Strength Index (14)
- 45.2
- 47.7
- Volatility (1 Year)
- 89.9%
- 64.2%
- Beta (5 Years)
- 1.75
- 1.05
MarginsIndustry
- Pretax Margin
- -57.8%
- -2.55%
- EBITDA Margin
- -48.8%
- -2.82%
- FCF Margin
- -35.2%
- 0.40%
Returns on capitalIndustry
- Return on Equity (ROE)
- -63.0%
- -17.1%
- Return on Assets (ROA)
- -28.0%
- -12.2%
- Return on Invested Capital (ROIC)
- -94.7%
- -3.22%
- Return on Capital Employed (ROCE)
- -33.6%
- -8.13%
Financial positionIndustry
- Current Ratio
- 4.86
- 2.45
- Quick Ratio
- 3.76
- 1.53
- Debt / Equity
- 1.18
- 0.42
- Interest Coverage
- -4.54
- -1.68
GrowthIndustry
- Revenue Growth (YoY)
- 1.58%
- 9.24%
- Revenue Growth (3Y CAGR)
- 1.17%
- 7.08%
- Revenue Growth (5Y CAGR)
- 19.1%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 0.48
- 0.59
- Inventory Turnover
- 1.50
- 2.20
- Revenue Per Employee
- $393.45K
- $330.60K
- Profits Per Employee
- -$229.48K
- -$41.39K
- Employee Count
- 310
- 186
- WACC
- 12.1%
- 9.71%
Income statement (TTM)Industry
- Pretax Income
- -$70.45M
- -$1.69M
Balance sheetIndustry
- Net Cash (Debt)
- $38.26M
- $3.73M
- Net Cash Per Share
- $2.04
- $0.24
- Equity (Book Value)
- $83.31M
- $63.44M
- Book Value Per Share
- $4.43
- $3.26
- Tangible Book Value
- $83.31M
- $11.04M
- Working Capital
- $171.77M
- $56.85M
Cash flow (TTM)Industry
- Capital Expenditures
- -$508.00K
- -$3.69M
- FCF Per Share
- -$2.28
- -$0.01
Dividends and yieldsIndustry
- Earnings Yield
- -98.0%
- -4.70%
- FCF Yield
- -59.1%
- 0.24%
Taxes and interestIndustry
- Interest Expense
- $13.76M
- $5.33M
- Income Tax
- $685.00K
- $1.63M
Scores and fair valueIndustry
- Altman Z-Score
- -6.61
- 2.44
- Piotroski F-Score
- 6
- 5
- Beneish M-Score
- -3.20
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | OM | S&P 500 | Difference | OM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -3.7% | -2.7% | −1.0 pts | ||
| 3 months | -14.2% | -1.7% | −12.5 pts | ||
| Year to date | +4.0% | +11.9% | −7.9 pts | ||
| 1 year | -30.3% | +12.0% | −42.3 pts | ||
| 3 years | -93.0% | +78.2% | −171.2 pts | -58.8% | +21.2% |
| 5 years | -99.5% | +73.2% | −172.7 pts | -65.3% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M OM shares were sold short on Oct 30, 2026, down 12.8% from the previous report, or 6.66% of the shares available to trade. At recent volumes it would take 8.6 days to buy them back. Over the last 20 sessions, 40.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 812,767 | -12.8% | 94,445 | 8.6 |
| Oct 15, 2026 | 932,559 | +17.6% | 246,119 | 3.8 |
| Sep 30, 2026 | 792,696 | -10.9% | 133,657 | 5.9 |
| Sep 15, 2026 | 889,575 | -1.3% | 143,886 | 6.2 |
| Aug 31, 2026 | 901,682 | -3.7% | 129,027 | 7.0 |
| Aug 14, 2026 | 936,341 | -18.0% | 156,913 | 6.0 |
| Jul 31, 2026 | 1,142,402 | -6.1% | 103,656 | 11.0 |
| Jul 15, 2026 | 1,216,685 | -18.5% | 193,746 | 6.3 |
| Jun 30, 2026 | 1,493,147 | -24.2% | 456,798 | 3.3 |
| Jun 15, 2026 | 1,970,839 | -11.4% | 185,753 | 10.6 |
| May 29, 2026 | 2,223,191 | +8.2% | 168,323 | 13.2 |
| May 15, 2026 | 2,054,656 | +2.2% | 215,360 | 9.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?